397 related articles for article (PubMed ID: 16093978)
1. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.
Whittemore AS; Cirillo PM; Feldman D; Cohn BA
J Urol; 2005 Sep; 174(3):872-6; discussion 876. PubMed ID: 16093978
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen as predictor of prostate cancer in black men and white men.
Whittemore AS; Lele C; Friedman GD; Stamey T; Vogelman JH; Orentreich N
J Natl Cancer Inst; 1995 Mar; 87(5):354-60. PubMed ID: 7531773
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
5. Dietary manipulation, ethnicity, and serum PSA levels.
Eastham JA; Riedel E; Latkany L; Fleisher M; Schatzkin A; Lanza E; Shike M;
Urology; 2003 Oct; 62(4):677-82. PubMed ID: 14550442
[TBL] [Abstract][Full Text] [Related]
6. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
7. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
8. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
9. Race and the linkage between serum prostate-specific antigen and prostate cancer: a study of American veterans.
Vollmer RT
Am J Clin Pathol; 2004 Sep; 122(3):338-44. PubMed ID: 15362363
[TBL] [Abstract][Full Text] [Related]
10. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
[TBL] [Abstract][Full Text] [Related]
11. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen testing among young men: an opportunity to improve value.
Lange SM; Ambrose JP; Flynn MC; Lowrance WT; Hanson HA; O'Neil BB
Cancer Med; 2021 Mar; 10(6):2075-2079. PubMed ID: 33626214
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
15. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
Fowler JE; Bigler SA; Kilambi NK; Land SA
Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in operating characteristics of prostate cancer screening tests.
Smith DS; Bullock AD; Catalona WJ
J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
[TBL] [Abstract][Full Text] [Related]
17. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
[TBL] [Abstract][Full Text] [Related]
19. Potential effect of anti-inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy.
Kryvenko ON; Wang Y; Sadasivan S; Gupta NS; Rogers C; Bobbitt K; Chitale DA; Rundle A; Tang D; Rybicki BA
Prostate; 2019 Jul; 79(10):1090-1098. PubMed ID: 31045267
[TBL] [Abstract][Full Text] [Related]
20. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer.
Eastham JA; Sartor O; Richey W; Moparty B; Sullivan J
J La State Med Soc; 2001 Apr; 153(4):184-9. PubMed ID: 11394329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
